Zepp Health Corporation

NYSE ZEPP

Zepp Health Corporation Price to Sales Ratio (P/S) on December 30, 2024: 0.23

Zepp Health Corporation Price to Sales Ratio (P/S) is 0.23 on December 30, 2024, a 271.31% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Zepp Health Corporation 52-week high Price to Sales Ratio (P/S) is 0.31 on September 30, 2024, which is 32.82% above the current Price to Sales Ratio (P/S).
Zepp Health Corporation 52-week low Price to Sales Ratio (P/S) is 0.03 on June 28, 2024, which is -87.15% below the current Price to Sales Ratio (P/S).
Zepp Health Corporation average Price to Sales Ratio (P/S) for the last 52 weeks is 0.10.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NYSE: ZEPP

Zepp Health Corporation

CEO	Mr. Wang Huang
IPO Date	Feb. 8, 2018
Location	China
Headquarters	Building B2
Employees	839
Sector	Technology
Industries Smartphones Internet of Things (IoT)

Description

Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

Key trends

Past 5 years